Evercore ISI initiated coverage of Bio-Techne (TECH) with an Outperform rating and $75 price target The firm believes that current volatility creates a “nice entry point” for Bio-Techne as “end markets recover and strong OMx story is on deck.” The analyst sees EPS growth in the high teens percentage range.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TECH:
Questions or Comments about the article? Write to editor@tipranks.com